OPERATIONS
Cannsun has production, manufacturing and distribution throughout South Africa, Europe, Japan and Thailand. Our mission is to create natural formulations of adaptogens, cosmetics and cannabinoid products for the health and wellbeing of people across the world.
European Union
Aphaea Labs was developed in Greece utilizing botanical based ingredients with human optimization for our everyday lives. We have created lifestyle focused products for Mood, Sleep, Performance and Longevity in combination with THC Free EUGMP CBD isolate. These products are available for export within the EU and worldwide.
South Africa
- Africas largest medical cannabis cultivation license on 23-hectares with greenhouse and processing facilities (both GACP & South African GMP certified)
- Patient & Doctor portal launched March 2022 with full integration expected Q3 2022, visit cannhealthmd.com for more information
- Psilocybin cultivation licensing in progress, for research and development purposes
- BBBEE compliant, increasing participation of South African labor in economic activities: BBBEE Level 2 Company.
ASEAN
- Thailand: Own and operate a GMP production and manufacturing facility for cannabinoid extraction development of adaptogens and cosmetics.
- MOU with Mahasarakham University to develop cannabis genetics and Udon Thani Hospital to develop THC and CBD formulations for Clinical Trials relating to liver cancer
- Japan: Distribution partnerships of CBD products – adaptogens, cosmetics and other botanical medicines